Fintel reports that on January 10, 2025, JMP Securities downgraded their outlook for Paycor HCM (NasdaqGS:PYCR) from Market ...
JMP Securities analyst Constantine Davides lowered the firm’s price target on Evolent Health (EVH) to $18 from $27 and keeps an Outperform ...
JMP Securities reissued their market perform rating on shares of Stryker (NYSE:SYK – Free Report) in a research note issued ...
JMP Securities analyst Mitchell Germain maintained a Hold rating on W. P. Carey Inc. (WPC – Research Report) today. The company’s shares closed ...
JMP Securities has recently reduced Uber Technologies Inc (UBER) stock to Mkt Perform rating, as announced on January 2, 2025, according to Finviz. Earlier, on October 31, 2024, Gordon Haskett had ...
Fintel reports that on January 7, 2025, JMP Securities upgraded their outlook for LTC Properties (NYSE:LTC) from Market ...
Context Therapeutics (NASDAQ:CNTX – Get Free Report) was upgraded by Citizens Jmp to a “strong-buy” rating in a note issued ...
JMP Securities cited “the risk of antitrust penalties that could significantly impact Google’s U.S. distribution of search ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...
JMP Securities analyst Silvan Tuerkcan initiated coverage of enGene (ENGN) with an Outperform rating and $18 price target enGene is a clinical-stage biotechnology company focused on developing ...